About Index Trending news
Analyze
Pricing
PULMOCIDE LIMITED

PULMOCIDE LIMITED

Work at PULMOCIDE LIMITED? Add yourself to this profile

PULMOCIDE LIMITED

Pulmocide is focused on the development of inhaled medicines for the treatmentof viral and fungal infections of the respiratory tract.
Edit Profile
More info

Elsewhere

Contributors to this profile

Also headquartered in London

Reuters Reuters BBC BBC Blockchain Blockchain Vodafone Vodafone SwiftKey SwiftKey Ubuntu Ubuntu Virgin Virgin Charlie Charlie Volkswagen Volkswagen Deliveroo Deliveroo

Companies in the same industry

Medigus Medigus TESARO, Inc. TESARO, Inc. Inspire Medical Systems Inspire Medical Systems T2 Biosystems T2 Biosystems Novaerus Novaerus BlazeBioscience BlazeBioscience Anacor Pharmaceuticals Anacor Pharmaceuticals zappylab zappylab Achillion Pharmaceuticals Achillion Pharmaceuticals Mirna Therapeutics, Inc. Mirna Therapeutics, Inc.

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
20 Mar 2017
$30,000,000
Venture capital (Series B)
SV Life Sciences, F-Prime Capital Partners, Johnson & Johnson, +2

British biotech Pulmocide raises £24m in bid to find treatment for deadly lung diseases

The Telegraph
+1
26 Nov 2013
$27,541,217
Venture capital (Series A)